Literature DB >> 7243831

Evidence against a biphasic effect of acetaldehyde on voluntary ethanol consumption in rats.

C J Eriksson, R A Deitrich.   

Abstract

A group of 27 male Long-Evans rats was given a 2 week period of free-choice ethanol and consumed 1.26 +/- 1.27 g/kg/day (mean +/- SD). The animals were then divided into 3 groups. One group received the aldehyde dehydrogenase inhibitor, cyanamide, in their diet and an oral ethanol dose of 2 g/kg for 5 days. Another group received only the oral ethanol dose and the third, control, group received no treatment during these days. After the forced cyanamide and/or forced ethanol treatment, all of the rats were returned to the choice situation. Voluntary ethanol consumption was then followed for 2 months, during which time the control rats steadily increased their ethanol intake to 3.6 +/- 2.1 g/kg/day (mean +/- SD of last week's consumption). The cyanamide treatment caused a transient (3--4 day) decrease in the ethanol intake, after which the consumption increased to 3.7 +/- 2.9 g/kg/day. Consumption by the forced ethanol group (5.4 +/- 2.0 g/kg/day) was significantly greater (p less than 0.05) than that by the other rats. The present results do not favor a physiological role for acetaldehyde-induced formation of alkaloids in increasing voluntary ethanol consumption, but do support the notion of an acetaldehyde-mediated aversive effect on ethanol drinking.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7243831     DOI: 10.1016/s0091-3057(80)80044-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Ethanol preference in rats with a prior history of acetaldehyde self-administration.

Authors:  W Myers; K Ng; G Singer
Journal:  Experientia       Date:  1984-09-15

2.  Rapid hydroxylation of methtryptoline (1-methyltetrahydro-beta-carboline) in rat: identification of metabolites by chiral gas chromatography-mass spectrometry.

Authors:  O Beck; K F Faull; D B Repke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.